Open AccessDurability of VEGF Suppression With Intravitreal Aflibercept and Brolucizumab: Using Pharmacokinetic Modeling to Understand Clinical Outcomes
Author(s) -
Thomas Eißing,
Michael W. Stewart,
Cynthia X. Qian,
Kay D. Rittenhouse
Publication year - 2021
Publication title -
translational vision science and technology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.508
H-Index - 21
ISSN - 2164-2591
DOI - 10.1167/tvst.10.4.9
Subject(s) - cmin , aflibercept , ranibizumab , cmax , pharmacokinetics , medicine , ophthalmology , dosing , visual acuity , pharmacology , chemistry , bevacizumab , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom